CORRIGENDUM
- PMID: 28782161
- DOI: 10.1111/all.13171
CORRIGENDUM
Erratum for
-
Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.Allergy. 2016 Aug;71(8):1135-44. doi: 10.1111/all.12870. Epub 2016 Mar 31. Allergy. 2016. PMID: 27010957 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
